As the pathogenicity of LRRK2-mediated inflammation in AD remains mainly unexplored, and given that neuroinflammation widely contributes to AD, here, we explored whether LRRK2 regulates astrocytic activation in response to amyloid-β1-42 (Aβ1-42). This evidence concerns the gene LRRK2 and Alzheimer disease.